Rosetta Genomics Announces First
Selected Abstract
Rosetta Genomics Announces First Source for Clinical Validation of its Cancer of Unknown Primary (CUP) Diagnostic Test.
Samples Will be Analyzed Using Proprietary miRdicator(TM) Technology REHOVOT, Israel and DETROIT, Michigan, May 1 /PRNewswire-FirstCall/ -- Rosetta Genomics announced today that it has signed an agreement with the Henry Ford Hospital in Detroit, Michigan, one of the world's leading research centers ... May 1, 2007; PR Newswire
Read the full article with a free-trial membership at HighBeam Research
Related Articles 1.
Rosetta Genomics Announces First Source for Clinical Validation of its Cancer of Unknown Primary (CUP) Diagnostic Test.
|
